ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New Jersey » Geriatric Medicine

Top Geriatric Medicine Prescribers in New Jersey

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
LISA TANK MD

Geriatric Medicine

4,850

$253K

258
254 are 65+

5%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 29%

$52
Average prescription price

Avg: $67

SHENG YE MD

Geriatric Medicine

4,823

$271K

389
350 are 65+

4%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 29%

$56
Average prescription price

Avg: $67

MARY HAGGERTY MD

Geriatric Medicine

4,736

$349K

240
174 are 65+

12%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 29%

$74
Average prescription price

Avg: $67

SARITHA MATHEW MD

Geriatric Medicine

4,576

$288K

213
191 are 65+

19%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 29%

$63
Average prescription price

Avg: $67

AIJAZ HUSSAIN MD

Geriatric Medicine

4,382

$367K

396
384 are 65+

7%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 29%

$84
Average prescription price

Avg: $67

JUNE MAGALLANES M.D.

Geriatric Medicine

4,260

$232K

236
216 are 65+

15%
patients receiving schedule two controlled substances

Avg: 9%

18%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 29%

$54
Average prescription price

Avg: $67

JILL SCHWARTZ-CHEVLIN M.D.

Geriatric Medicine

3,986

$246K

173
166 are 65+

13%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 29%

$62
Average prescription price

Avg: $67

MUKESH SINGH M.D

Geriatric Medicine

3,869

$300K

181
155 are 65+

13%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 29%

$77
Average prescription price

Avg: $67

STEPHEN AIELLO M.D.

Geriatric Medicine

3,656

$279K

186
186 are 65+

10%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 29%

$76
Average prescription price

Avg: $67

JAMES WOLF M.D.

Geriatric Medicine

3,483

$261K

261
244 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

4%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 29%

$75
Average prescription price

Avg: $67

ALBERT RIDDLE MD

Geriatric Medicine

3,449

$277K

113
108 are 65+

15%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 29%

$80
Average prescription price

Avg: $67

LYNNE GRADINGER M.D.

Geriatric Medicine

3,377

$254K

84
82 are 65+

37%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 29%

$75
Average prescription price

Avg: $67

ZENAIDA DOIRANLIS MD

Geriatric Medicine

3,303

$183K

79
69 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 29%

$55
Average prescription price

Avg: $67

VINCENT ABENANTE MD

Geriatric Medicine

3,295

$272K

271
238 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

7%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 29%

$82
Average prescription price

Avg: $67

WINDSOR INTERNAL MEDICINE & GERIATRICS

Geriatric Medicine

3,052

$193K

149
84 are 65+

26%
patients receiving schedule two controlled substances

Avg: 9%

12%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 29%

$63
Average prescription price

Avg: $67

JOSE VIGARIO D.O.

Geriatric Medicine

2,924

$182K

240
225 are 65+

7%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 29%

$62
Average prescription price

Avg: $67

KALPANA CHEETI M.D.

Geriatric Medicine

2,891

$204K

345
307 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

5%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 29%

$70
Average prescription price

Avg: $67

MICHELE ELKINS M.D

Geriatric Medicine

2,844

$115K

123
119 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 29%

$40
Average prescription price

Avg: $67

PALAK MOONDRA DO

Geriatric Medicine

2,840

$152K

204
187 are 65+

5%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 29%

$53
Average prescription price

Avg: $67

GLENN ZWERIN M.D.

Geriatric Medicine

2,781

$194K

107
94 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

11%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 29%

$70
Average prescription price

Avg: $67

JAY MEYEROWITZ MD

Geriatric Medicine

2,562

$244K

190
184 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

9%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 29%

$95
Average prescription price

Avg: $67

KEERTI SHARMA M.D.

Geriatric Medicine

2,540

$150K

195
187 are 65+

10%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 29%

$59
Average prescription price

Avg: $67

SUDHA KOLLI MD

Geriatric Medicine

2,464

$159K

160
130 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 29%

$64
Average prescription price

Avg: $67

PRANAB HALDAR MD

Geriatric Medicine

2,439

$165K

66
57 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 29%

$67
Average prescription price

Avg: $67

URMI DAS M.D.

Geriatric Medicine

2,423

$170K

172
143 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 29%

$70
Average prescription price

Avg: $67

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank